Inclusion completed

Dose densified chemoimmunotherapy with early CNS prophylaxis in patients less than 65 years with high risk Diffuse Large B-Cell Lymphoma (NLG-LBC05)

Cancer type: Lymphoma

Phase: II

Principal Investigator: Leppä Sirpa

Country: FI

Keywords: Finland

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01325194?term=lepp%C3%A4&rank=1